Prospective genomically guided identification of “early/evolving” and “undersampled” IDH-wildtype glioblastoma leads to improved clinical outcomes

BACKGROUND: Genomic profiling studies of diffuse gliomas have led to new improved classification schemes that better predict patient outcomes compared to conventional histomorphology alone. One example is the recognition that patients with IDH-wildtype diffuse astrocytic gliomas demonstrating lower-...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yalan, Lucas, Calixto-Hope G, Young, Jacob S, Morshed, Ramin A, McCoy, Lucie, Oberheim Bush, Nancy Ann, Taylor, Jennie W, Daras, Mariza, Butowski, Nicholas A, Villanueva-Meyer, Javier E, Cha, Soonmee, Wrensch, Margaret, Wiencke, John K, Lee, Julieann C, Pekmezci, Melike, Phillips, Joanna J, Perry, Arie, Bollen, Andrew W, Aghi, Manish K, Theodosopoulos, Philip, Chang, Edward F, Hervey-Jumper, Shawn L, Berger, Mitchel S, Clarke, Jennifer L, Chang, Susan M, Molinaro, Annette M, Solomon, David A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527525/
https://www.ncbi.nlm.nih.gov/pubmed/35395677
http://dx.doi.org/10.1093/neuonc/noac089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527525/
https://www.ncbi.nlm.nih.gov/pubmed/35395677
http://dx.doi.org/10.1093/neuonc/noac089

Ejemplares similares